Cortsizol as a stress marker and cognitive disorders indicator in patients with acute myocardial infarction
PDF (Українська)

Keywords

acute myocardial infarction
cortisol
intensive care
cognitive disorders

How to Cite

Stroenko, E. (2020). Cortsizol as a stress marker and cognitive disorders indicator in patients with acute myocardial infarction. Medicine Today and Tomorrow, 78(1), 58–64. Retrieved from https://msz.knmu.edu.ua/article/view/351

Abstract

The study included 105 patients with acute myocardial infraction in three groups: 34–40; 41–50 and 51–60 years old. The state of cognitive functions were studied using neuropsychological methods: MMSE, clock drawing test, test «memorizing 10 words» by A.R. Luria. There are 3 treatment regimens: the first treatment regimen – by quercetin; the second – by quercetin + 2ethyl-6-methyl-3-hydroxypyrimidine succinate; the third – quercetin + morpholinium – 3-methyl-1,2,4-triazolin-5-thiocetam. It is established a significant increase of cortisol blood serum level in all age groups of patients. The concentration of cortisol was highest in patients 34–40 years, which indicates a much more severe course of acute myocardial infarction. Patients receiving treatment with morpholinium-3-methyl-1,2,4-triazolin-5-tiocetam showed a decrease in cortisol concentrations already at the 3rd day of treatment. Reducing the cortisol concentration in blood serum in patients suffering from acute myocardial infarction confirms the indicators of neuropsychological tests and indicates a recurrence of cognitive impairment. When morpholinium-3-methyl-1,2,4-triazoline-5-tiocetam was added to standard therapy, there was a significant decrease in serum cortisol levels and cognitive impairment in patients with acute myocardial infarction under the age of 60 years. We confirmed that the definition of cortisol, as the main marker of stress, is promising and requires further study.

PDF (Українська)

References

Бильченко А. В. Когнитивные нарушения и деменция у пациентов с артериальной гипертензией / А. В. Бильченко, Л. В. Матюха // Український медичний часопис. – 2014. – № 6 (104). – С. 71–76.

Heart Disease and Stroke Statistics – 2017 Update: A Report From the American Heart Association / E. J. Benjamin, M. J. Blaha, S. E. Chiuve [et al.] // Circulation. – 2017. – Vol. 135 (10). – e146–e603.

Кожухов С. Н. Научные доказательства оптимизации терапии больных c хронической сердечной недостаточностью на фоне ишемической болезни сердца / С. Н. Кожухов // Серцева недостатність та коморбідні стани. – 2017. – № 1. – С. 39–45.

Гандзюк В. А. Аналіз захворюваності на ішемічну хворобу серця в Україні / В. А. Гандзюк // Український кардіологічний журнал. – 2014. – № 3. – C. 45–52.

Evropean cardiovascular disease statistics / compiled by Melanie Nichols, Nick Townsend, Peter Scarborough, Mike Rayner. – [2012 ed.]. – 2012. – 125 p.

Quality of life in adult survivors of critical illness: a systematic review of the literature / D. W. Dowdy, M. P. Eid, A. Sedrakyan [et al.] // Intensive Care Medicine. – 2015. – Vol. 31 (5). – P. 611–620.

Plasma cortisol and prognosis of patients with acute myocardial infarction / S. K. Jutla, M. F. Yuyun, P. A. Quinn, L. L. Nq // Journal of Cardiavascular Medicine. – 2014. – Vol. 15, issue 1. – P. 33–41.

Rooij S. R. Blunted cardiovascular and cortisol reactivity to acute psychological stress: a summary of results from the Dutch Famine Birth Cohort Study / S. R. Rooij // International Journal of Psychophysiology. – 2013. – Vol. 90 issue 1. – P. 21–27.